Last reviewed · How we verify
Group O
At a glance
| Generic name | Group O |
|---|---|
| Sponsor | Bursa Yuksek Ihtisas Training and Research Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Intermountain Stewardship in Community Outpatient Settings-Resources & Engagement-Pediatrics
- Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Tonsillectomy (NA)
- Clinical Study of Lung Protective Ventilation Strategies and Tumor Microenvironment (NA)
- Effects of Positive End-Expiratory Pressure Levels on Lung Recruitment Duration and Hemodynamics After Alveolar Recruitment Maneuver: A Randomized Clinical Trial (NA)
- Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS (NA)
- Determination of the Optimal Inspiratory Pressure to Decrease Incidence of Gastric Insufflation With Adequate Ventilation During Facemask Ventilation in Morbidly Obese Patients (NA)
- Different Education Methods and Self Vulvar Examination (SVE) (NA)
- LTV (Low Tidal Volüme) Ventilation and Diaphragmatic Motion in CABG (Coronary Artery Bypass Grafting) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Group O CI brief — competitive landscape report
- Group O updates RSS · CI watch RSS
- Bursa Yuksek Ihtisas Training and Research Hospital portfolio CI